Shuttle Pharmaceuticals Holdings Inc (SHPH)

Apr 21, 2025

Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025 - GlobeNewswire

Apr 21, 2025

Apr 21, 2025

Shuttle Pharma's Latest Glioblastoma Trial Data and Cancer Diagnostic Advances: Key Updates Coming April 23 - Stock Titan

Apr 21, 2025

Apr 17, 2025

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Sees Significant Growth in Short Interest - Defense World

Apr 17, 2025

Apr 15, 2025

Shuttle Pharmaceuticals (NASDAQ:SHPH) Trading Down 16.7% – Here’s Why - Defense World

Apr 15, 2025

Apr 10, 2025

Shuttle Pharma files patent for cancer treatment innovation By Investing.com - Investing.com Canada

Apr 10, 2025

Apr 10, 2025

Shuttle Pharmaceuticals Files Provisional US Patent to Treat Prostrate Cancer - marketscreener.com

Apr 10, 2025

Apr 10, 2025

Shuttle Pharma files patent for cancer treatment innovation - Investing.com Australia

Apr 10, 2025

Apr 10, 2025

Shuttle Pharmaceuticals Files Provisional Patent Application For PSMA Ligand Conjugates To Treat Prostate Cancer - marketscreener.com

Apr 10, 2025

Apr 10, 2025

Shuttle Pharma Developing Pretreatment Diagnostic Blood - GlobeNewswire

Apr 10, 2025

Apr 10, 2025

Game-Changing Prostate Cancer Treatment: Shuttle Pharma Unveils Breakthrough PSMA Technology - Stock Titan

Apr 10, 2025

Apr 08, 2025

Head to Head Analysis: Shuttle Pharmaceuticals (NASDAQ:SHPH) vs. Phibro Animal Health (NASDAQ:PAHC) - Defense World

Apr 08, 2025

Apr 07, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Apr 07, 2025

Apr 04, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Apr 04, 2025

Mar 31, 2025

Shuttle Pharmaceuticals Appoints New Interim CEO and CSO - TipRanks

Mar 31, 2025

Mar 25, 2025

Shuttle Pharmaceuticals signs consulting deal with Bowery Group By Investing.com - Investing.com Australia

Mar 25, 2025

Mar 25, 2025

Shuttle Pharmaceuticals signs consulting deal with Bowery Group - Investing.com

Mar 25, 2025

Mar 25, 2025

Shuttle Pharmaceuticals Holdings IncOn March 21, Enters Consulting Agreement With Bowery ConsultingSEC Filing - Marketscreener.com

Mar 25, 2025

Mar 24, 2025

Growth Stocks Are Beaten Down. Why It’s Temporary and What Should Be On Your Shopping List Instead - Asianet Newsable

Mar 24, 2025

Mar 22, 2025

Shuttle Pharmaceuticals (NASDAQ:SHPH) Stock Price Up 3.8% – Should You Buy? - Defense World

Mar 22, 2025

Mar 19, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Mar 19, 2025

Mar 17, 2025

SHPH stock touches 52-week low at $0.34 amid market challenges - Investing.com

Mar 17, 2025

Mar 17, 2025

SHPH stock touches 52-week low at $0.34 amid market challenges By Investing.com - Investing.com South Africa

Mar 17, 2025

Mar 17, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Mar 17, 2025

Mar 14, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Mar 14, 2025

Mar 14, 2025

SHPHSHUTTLE PHARMACTCLS HLDGS INC Latest Stock News & Market Updates - Stock Titan

Mar 14, 2025

Mar 13, 2025

Shuttle Pharma Announces Closing Of $5.75 Million Underwritten Offering -March 13, 2025 at 05:39 pm EDT - Marketscreener.com

Mar 13, 2025

Mar 13, 2025

Shuttle Pharma Secures $5.2M in Public Offering - TipRanks

Mar 13, 2025

Mar 13, 2025

Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering - GlobeNewswire

Mar 13, 2025

Mar 13, 2025

Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering - Benzinga

Mar 13, 2025

Mar 13, 2025

Shuttle Pharma Raises $5.75M: Strategic Boost for Revolutionary Cancer Treatment Trial - StockTitan

Mar 13, 2025

Mar 12, 2025

Shuttle Pharma appoints new interim co-CEO By Investing.com - Investing.com Australia

Mar 12, 2025

Mar 12, 2025

This Md. biotech wants to get a cancer treatment to patients. It just tapped an industry outsider as co-CEO. - The Business Journals

Mar 12, 2025

Mar 12, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Mar 12, 2025

Mar 12, 2025

Shuttle Pharma announces $5.75 million stock offering - Investing.com India

Mar 12, 2025

Mar 12, 2025

Shuttle Pharma announces $5.75 million stock offering By Investing.com - Investing.com Canada

Mar 12, 2025

Mar 12, 2025

Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering -March 12, 2025 at 09:25 am EDT - Marketscreener.com

Mar 12, 2025

Mar 12, 2025

Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering - GlobeNewswire

Mar 12, 2025

Mar 12, 2025

Shuttle Pharma Secures Critical $5.75M Funding for Revolutionary Cancer Radiation Therapy - StockTitan

Mar 12, 2025

Mar 12, 2025

4 Artificial Intelligence (AI) Stocks Worth Buying in the Tech Sell-Off - The Globe and Mail

Mar 12, 2025

Mar 12, 2025

Lucid Group (LCID) Prepares to Sink Into Penny Stock Territory - The Globe and Mail

Mar 12, 2025

Mar 12, 2025

1 Large-Cap Stock with Solid Fundamentals and 2 to Avoid - The Globe and Mail

Mar 12, 2025

Mar 12, 2025

Shuttle Pharma appoints new interim co-CEO - Investing.com

Mar 12, 2025

Mar 12, 2025

Shuttle Pharma Appoints Christopher Cooper as Interim Co-CEO - citybiz

Mar 12, 2025

Mar 12, 2025

Shuttle Pharmaceuticals appoints Christopher Cooper as interim Co-CEO - TipRanks

Mar 12, 2025

Mar 12, 2025

Shuttle Pharma Announces Appointment Of Christopher Cooper As Interim Co-CEO To Enhance Business Activities - Marketscreener.com

Mar 12, 2025

Mar 12, 2025

Shuttle Pharmaceuticals Appoints Christopher Cooper as Co-CEO - TipRanks

Mar 12, 2025

Mar 12, 2025

Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities - GlobeNewswire

Mar 12, 2025

Mar 12, 2025

2 Reasons to Watch GE and 1 to Stay Cautious - The Globe and Mail

Mar 12, 2025

Mar 07, 2025

SHPH stock touches 52-week low at $0.5 amid sharp annual decline - Investing.com Australia

Mar 07, 2025

Mar 07, 2025

SHPH stock touches 52-week low at $0.5 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 07, 2025